Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $253,750 - $275,512
8,212 New
8,212 $259,000
Q2 2022

Aug 15, 2022

SELL
$23.75 - $31.69 $33,345 - $44,492
-1,404 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$19.97 - $26.94 $3,514 - $4,741
-176 Reduced 11.14%
1,404 $36,000
Q4 2021

Feb 11, 2022

BUY
$17.46 - $21.61 $27,586 - $34,143
1,580 New
1,580 $32,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.